Safety degree assessment of drugs used in conscious sedation for colonoscopy in patients that develop respiratory depression

Detalhes bibliográficos
Autor(a) principal: Rech,Fernanda Maraschin
Data de Publicação: 2017
Outros Autores: Kock,Kaiser de Souza, Bellei,Amanda Colpani
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Journal of Coloproctology (Rio de Janeiro. Online)
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S2237-93632017000100031
Resumo: ABSTRACT Objective: To analyze the safety degree of drugs used in colonoscopy during conscious sedation in patients developing respiratory depression. Methods: Cross-sectional observational study that evaluated 1120 patients who underwent colonoscopy between February 2015 and February 2016. Physical characteristics, surgical history and previous colonoscopies, indication and conditions of the current examination, fentanyl and midazolam doses and subsequent complications were analyzed. Level of significance: p < 0.05. Chi-square test was used for association of categorical variables, whereas Student's t test was used to compare means and Spearman's coefficient for correlation. Results: There were 661 female (59%) and 459 (41%) male patients, with a mean age of 54.90 (20-87) years and BMI of 27.00 (14.5-45.4). Of the 1120 patients, only 2 (0.2%) had respiratory depression, reversed with lanexat. Patients who had complications were of both genders, with a body mass index of 21.25 and 28.7. There was a correlation between the required dose of fentanyl and age (p < 0.001 to −0.121 Spearman's coefficient), as well as midazolam (p < 0.001 - Spearman's coefficient −0.452) and increasing age was associated with a lower dose of the drug. Conclusion: The number of patients with complications was 0.17%. The age of the patient showed an inverse association, i.e., the older the patient, the lower the required dose of medication. The drugs used in colonoscopy show a high degree of safety, corroborating their frequent use for superficial/conscious sedation in this procedure.
id SBCP-1_ce7e9255d59887c9638611d92292b221
oai_identifier_str oai:scielo:S2237-93632017000100031
network_acronym_str SBCP-1
network_name_str Journal of Coloproctology (Rio de Janeiro. Online)
repository_id_str
spelling Safety degree assessment of drugs used in conscious sedation for colonoscopy in patients that develop respiratory depressionColonoscopyConscious sedationComplicationSedationRespiratory depressionABSTRACT Objective: To analyze the safety degree of drugs used in colonoscopy during conscious sedation in patients developing respiratory depression. Methods: Cross-sectional observational study that evaluated 1120 patients who underwent colonoscopy between February 2015 and February 2016. Physical characteristics, surgical history and previous colonoscopies, indication and conditions of the current examination, fentanyl and midazolam doses and subsequent complications were analyzed. Level of significance: p < 0.05. Chi-square test was used for association of categorical variables, whereas Student's t test was used to compare means and Spearman's coefficient for correlation. Results: There were 661 female (59%) and 459 (41%) male patients, with a mean age of 54.90 (20-87) years and BMI of 27.00 (14.5-45.4). Of the 1120 patients, only 2 (0.2%) had respiratory depression, reversed with lanexat. Patients who had complications were of both genders, with a body mass index of 21.25 and 28.7. There was a correlation between the required dose of fentanyl and age (p < 0.001 to −0.121 Spearman's coefficient), as well as midazolam (p < 0.001 - Spearman's coefficient −0.452) and increasing age was associated with a lower dose of the drug. Conclusion: The number of patients with complications was 0.17%. The age of the patient showed an inverse association, i.e., the older the patient, the lower the required dose of medication. The drugs used in colonoscopy show a high degree of safety, corroborating their frequent use for superficial/conscious sedation in this procedure.Sociedade Brasileira de Coloproctologia2017-03-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S2237-93632017000100031Journal of Coloproctology (Rio de Janeiro) v.37 n.1 2017reponame:Journal of Coloproctology (Rio de Janeiro. Online)instname:Sociedade Brasileira de Coloproctologia (SBCP)instacron:SBCP10.1016/j.jcol.2016.09.003info:eu-repo/semantics/openAccessRech,Fernanda MaraschinKock,Kaiser de SouzaBellei,Amanda Colpanieng2017-03-23T00:00:00Zoai:scielo:S2237-93632017000100031Revistahttp://www.scielo.br/scielo.php?script=sci_serial&pid=2237-9363&lng=pt&nrm=isohttps://old.scielo.br/oai/scielo-oai.php||sbcp@sbcp.org.br2317-64232237-9363opendoar:2017-03-23T00:00Journal of Coloproctology (Rio de Janeiro. Online) - Sociedade Brasileira de Coloproctologia (SBCP)false
dc.title.none.fl_str_mv Safety degree assessment of drugs used in conscious sedation for colonoscopy in patients that develop respiratory depression
title Safety degree assessment of drugs used in conscious sedation for colonoscopy in patients that develop respiratory depression
spellingShingle Safety degree assessment of drugs used in conscious sedation for colonoscopy in patients that develop respiratory depression
Rech,Fernanda Maraschin
Colonoscopy
Conscious sedation
Complication
Sedation
Respiratory depression
title_short Safety degree assessment of drugs used in conscious sedation for colonoscopy in patients that develop respiratory depression
title_full Safety degree assessment of drugs used in conscious sedation for colonoscopy in patients that develop respiratory depression
title_fullStr Safety degree assessment of drugs used in conscious sedation for colonoscopy in patients that develop respiratory depression
title_full_unstemmed Safety degree assessment of drugs used in conscious sedation for colonoscopy in patients that develop respiratory depression
title_sort Safety degree assessment of drugs used in conscious sedation for colonoscopy in patients that develop respiratory depression
author Rech,Fernanda Maraschin
author_facet Rech,Fernanda Maraschin
Kock,Kaiser de Souza
Bellei,Amanda Colpani
author_role author
author2 Kock,Kaiser de Souza
Bellei,Amanda Colpani
author2_role author
author
dc.contributor.author.fl_str_mv Rech,Fernanda Maraschin
Kock,Kaiser de Souza
Bellei,Amanda Colpani
dc.subject.por.fl_str_mv Colonoscopy
Conscious sedation
Complication
Sedation
Respiratory depression
topic Colonoscopy
Conscious sedation
Complication
Sedation
Respiratory depression
description ABSTRACT Objective: To analyze the safety degree of drugs used in colonoscopy during conscious sedation in patients developing respiratory depression. Methods: Cross-sectional observational study that evaluated 1120 patients who underwent colonoscopy between February 2015 and February 2016. Physical characteristics, surgical history and previous colonoscopies, indication and conditions of the current examination, fentanyl and midazolam doses and subsequent complications were analyzed. Level of significance: p < 0.05. Chi-square test was used for association of categorical variables, whereas Student's t test was used to compare means and Spearman's coefficient for correlation. Results: There were 661 female (59%) and 459 (41%) male patients, with a mean age of 54.90 (20-87) years and BMI of 27.00 (14.5-45.4). Of the 1120 patients, only 2 (0.2%) had respiratory depression, reversed with lanexat. Patients who had complications were of both genders, with a body mass index of 21.25 and 28.7. There was a correlation between the required dose of fentanyl and age (p < 0.001 to −0.121 Spearman's coefficient), as well as midazolam (p < 0.001 - Spearman's coefficient −0.452) and increasing age was associated with a lower dose of the drug. Conclusion: The number of patients with complications was 0.17%. The age of the patient showed an inverse association, i.e., the older the patient, the lower the required dose of medication. The drugs used in colonoscopy show a high degree of safety, corroborating their frequent use for superficial/conscious sedation in this procedure.
publishDate 2017
dc.date.none.fl_str_mv 2017-03-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S2237-93632017000100031
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S2237-93632017000100031
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1016/j.jcol.2016.09.003
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Sociedade Brasileira de Coloproctologia
publisher.none.fl_str_mv Sociedade Brasileira de Coloproctologia
dc.source.none.fl_str_mv Journal of Coloproctology (Rio de Janeiro) v.37 n.1 2017
reponame:Journal of Coloproctology (Rio de Janeiro. Online)
instname:Sociedade Brasileira de Coloproctologia (SBCP)
instacron:SBCP
instname_str Sociedade Brasileira de Coloproctologia (SBCP)
instacron_str SBCP
institution SBCP
reponame_str Journal of Coloproctology (Rio de Janeiro. Online)
collection Journal of Coloproctology (Rio de Janeiro. Online)
repository.name.fl_str_mv Journal of Coloproctology (Rio de Janeiro. Online) - Sociedade Brasileira de Coloproctologia (SBCP)
repository.mail.fl_str_mv ||sbcp@sbcp.org.br
_version_ 1752126477900447744